
Reta
Retatrutide, also known as LY3437943, is a modified 39-amino-acid peptide being investigated as a single-molecule agonist of three metabolic receptors: GLP-1 receptor GIP receptor Glucagon receptor Research focuses on energy balance, glucose regulation, appetite signaling, lipid metabolism and body-weight regulation. Retatrutide remains investigational and is not approved by the FDA for human or veterinary use.
- Metabolic signaling
- Glucose and insulin-response pathways
- Appetite and satiety signaling
- Energy expenditure
- Lipid metabolism
- Body-weight regulation
- Liver-fat and metabolic-dysfunction research
- Gastric-emptying effects
20mg 10mg
Store lyophilized retatrutide refrigerated at 2–8°C, protected from light and moisture. For extended storage, follow the batch-specific stability data and COA.
Every batch, fully traceable.
Download analytical panels and browse related documentation.
HPLC + Mass Spec assay report.
Reconstitution, storage, and shelf life.
Cited studies for this compound.
Common questions about this compound.

